AOD-9604 vs HGH Fragment 176-191
Well Studied vs Moderate Research
avoid Researched · 95% Same mechanism of action. AOD-9604 is a modified version of this fragment; using both is redundant and unnecessary.
Molecular Data
AOD-9604 HGH Fragment 176-191
Weight 1,815.1 Da 1,817.1 Da
Half-life 3-4 minutes 15-20 minutes
Chain 17 amino acids 16 amino acids
Type Modified hGH C-terminal fragment hGH C-terminal fragment (176-191)
Key Benefits
AOD-9604
01 Targets fat loss through selective lipolysis
02 Avoids growth hormone side effects
03 No effect on blood glucose or insulin
04 Does not increase IGF-1 levels
05 Metabolically safer than full hGH
06 Emerging cartilage repair potential
HGH Fragment 176-191
01 Stimulates lipolysis without growth hormone side effects
02 Does not affect blood glucose or insulin sensitivity
03 Does not increase IGF-1 levels
04 Selectively targets fat metabolism
05 No impact on bone or organ growth
Dosing Protocols
AOD-9604
250-500mcg / Once daily
Fat loss - Standard 250-300mcg Once daily (morning, fasted)
Enhanced fat loss 400-500mcg Once daily (morning, fasted)
Joint support 250mcg Once daily
Conservative start 200mcg Once daily
HGH Fragment 176-191
250-500mcg / Twice daily (fasted)
Fat loss - Standard 250mcg Twice daily (morning fasted + pre-bed)
Enhanced fat loss 500mcg Twice daily (morning fasted + pre-bed)
Conservative start 250mcg Once daily (morning, fasted)
Side Effects
AOD-9604
Generally well-tolerated in clinical trials
Mild injection site reactions possible
No reported effects on blood glucose or insulin
HGH Fragment 176-191
Injection site irritation (redness, mild swelling)
Headache, particularly in the first few days
Generally well-tolerated with a favorable safety profile
Contraindications
Pregnancy or breastfeeding
WADA prohibited - athletes subject to testing must avoid
Pregnancy or breastfeeding
Active cancer or history of malignancy
WADA prohibited - athletes subject to testing must avoid
Research Evidence
AOD-9604 HGH Fragment 176-191
Status Well Studied Moderate Research
References 5 studies 4 studies
Latest 2014 2014
FDA Approved No No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.